Veracyte (VCYT) Misses Q4 EPS by 8c, Slight Beat on Revenues; Offers FY20 Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. AWK
9. ACN
10. USO

Go back to Veracyte (VCYT) Misses Q4 EPS by 8c, Slight Beat on Revenues; Offers FY20 Revenue Guidance Above Consensus

Veracyte Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides 2020 Financial Outlook

February 25, 2020 4:05 PM EST

2019 Total Revenue Grew 31% to $120.4 Million; Genomic Test Volume Grew 25% to 39,612

Achieved Fourth Quarter 2019 Positive Cash Flow from Operations

Fourth Quarter Acquisition Positions Company for Global Expansion

Conference Call and Webcast Today at 5:00 p.m. ET

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc., (Nasdaq:... More